PrediXcan Based Analysis

Introduction of PrediXcan

  • Genome-wide Association Study (GWAS) is an important tool for detecting genes related to complex diseases or biological traits, such as diabetes and cancer, animal and plant traits. Genome-wide association studies identify single nucleotide polymorphisms (which occur more frequently in individuals with diseases or target traits) to determine the mechanism of action of these associations. However, due to gene regulation, most disease-related mutations do not change the function of a gene, but change the number of genes replicated in the cell. Therefore, only through genome-wide association studies still cannot solve the problem.
  • Transcriptome research can study gene expression and regulation mechanisms and their relationship with diseases to overcome this limitation of genome-wide association studies. However, transcriptome research cannot determine reverse causality-such as whether the expression level of a gene will change due to the occurrence of a disease, or whether the occurrence of a disease is caused by a change in gene expression.
  • Based on the above problems, PrediXcan was developed to detect the relationship between genes and traits. PrediXcan integrates transcriptome data and GWAS data into a single computing framework. To determine the correlation between gene expression levels and disease states or target characteristics.
Fig 1. Introduction of PrediXcan.

Fig 1. Introduction of PrediXcan.

Basic Principles of PrediXcan

The premise of PrediXcan is that the expression level of genes in the organism is mainly regulated by genetic factors, disease states and some other factors. The purpose of PrediXcan is to establish the relationship between genetically regulated gene expression and traits.

Fig 2. Mechanism tested by the PrediXcan method.

Fig 2. Mechanism tested by the PrediXcan method.

The analysis process mainly includes the following two steps:

Fig 3. PrediXcan frameworks, the workflow illustrates the steps used in developing the PrediXcan method.

Fig 3. PrediXcan frameworks, the workflow illustrates the steps used in developing the PrediXcan method. (Eric, R, G, et al. 2015)

Advantages of PrediXcan

  • Identify potential pathogenic genes
  • Study the relationship between gene expression levels (high or low) and diseases or traits
  • Validation studies only need to test thousands of genes at most, instead of millions of potential single-gene mutations, thereby saving computing resources
  • The existing genomic data can be re-analyzed to fill the gaps in GWAS research.

Artificial Intelligence in PrediXcan

Protheragen provides analysis services based on PrediXcan. PrediXcan is a gene-based association analysis software. With the help of artificial intelligence machine learning, it helps you quickly establish the relationship between genetically regulated gene expression and disease or biological traits.

Artificial Intelligence in PrediXcan

References

  • Eric, R, G, et al. A gene-based association method for mapping traits using reference transcriptome data.[J]. Nature Genetics, 2015. Sep;47(9):1091-8.

Online Inquiry

Please submit a detailed description of your project. We will provide you with a customized project plan to meet your research requests. You can also send emails directly to inquiry@protheragen.com for inquiries.

Please input "protheragen" as verification code.

  • 2200 Smithtown Avenue, Room 1, Ronkonkoma, NY 11779-7329, USA
  • Phone: 1-516-666-0889
  • Fax: 1-516-927-0118
  • Email: inquiry@protheragen.com

protheragen

Copyright © 2005-2020 [ Protheragen ] All Rights Reserved.